SIGLEC5 Polyclonal antibody

SIGLEC5 Polyclonal Antibody for WB, ELISA
Cat No. 13230-1-AP

Host / Isotype

Rabbit / IgG

Reactivity

human

Applications

WB, IHC, ELISA

CD170, CD33 antigen like 2, CD33L2, OB binding protein 2, OB BP2, OBBP2, Obesity binding protein 2, SIGLEC 5, SIGLEC5

Formulation:  PBS and Azide
PBS and Azide
Conjugate:  Unconjugated
Unconjugated
Size/Concentration: 

-/ -

Freight/Packing: -

Quantity

Please visit your regions distributor:


Tested Applications

Positive WB detected inTHP-1 cells

Recommended dilution

ApplicationDilution
Western Blot (WB)WB : 1:500-1:2000
It is recommended that this reagent should be titrated in each testing system to obtain optimal results.
Sample-dependent, Check data in validation data gallery.

Published Applications

IHCSee 1 publications below

Product Information

13230-1-AP targets SIGLEC5 in WB, IHC, ELISA applications and shows reactivity with human samples.

Tested Reactivity human
Cited Reactivityhuman
Host / Isotype Rabbit / IgG
Class Polyclonal
Type Antibody
Immunogen SIGLEC5 fusion protein Ag4101 Predict reactive species
Full Name sialic acid binding Ig-like lectin 5
Calculated Molecular Weight 551 aa, 61 kDa
Observed Molecular Weight 70 kDa
GenBank Accession NumberBC029896
Gene Symbol SIGLEC5
Gene ID (NCBI) 8778
RRIDAB_10643385
Conjugate Unconjugated
Form Liquid
Purification MethodAntigen affinity purification
UNIPROT IDO15389
Storage Buffer PBS with 0.02% sodium azide and 50% glycerol , pH 7.3
Storage ConditionsStore at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA.

Protocols

Product Specific Protocols
WB protocol for SIGLEC5 antibody 13230-1-APDownload protocol
Standard Protocols
Click here to view our Standard Protocols

Publications

SpeciesApplicationTitle
humanIHC

Sci Rep

Siglec-5 is a novel marker of critical limb ischemia in patients with diabetes.

Authors - Ju-Yi Li

Cell Death Dis

METTL14 contributes to acute lung injury by stabilizing NLRP3 expression in an IGF2BP2-dependent manner

Authors - Fei Cao
Loading...